Free Trial
NASDAQ:GENE

Genetic Technologies (GENE) Stock Price, News & Analysis

Genetic Technologies logo
$0.76 0.00 (0.00%)
As of 05/20/2025

About Genetic Technologies Stock (NASDAQ:GENE)

Key Stats

Today's Range
$0.77
$0.77
50-Day Range
$0.77
$0.77
52-Week Range
$0.67
$3.77
Volume
N/A
Average Volume
N/A
Market Capitalization
$3.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GENE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genetic Technologies and its competitors with MarketBeat's FREE daily newsletter.

GENE Stock News Headlines

This Cold War “Accident” Could Unleash New $100 Trillion AI Boom
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
See More Headlines

GENE Stock Analysis - Frequently Asked Questions

Genetic Technologies' stock was trading at $0.7650 at the start of the year. Since then, GENE shares have increased by 0.0% and is now trading at $0.7650.

Shares of Genetic Technologies reverse split before market open on Monday, December 4th 2023.The 1-5 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Shares of GENE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genetic Technologies investors own include Netflix (NFLX), Plug Power (PLUG), Meta Platforms (META), OPKO Health (OPK), Nokia (NOK), Novavax (NVAX) and iBio (IBIO).

Company Calendar

Today
7/10/2025
Next Earnings (Estimated)
7/28/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GENE
CIK
1166272
Employees
50
Year Founded
1989

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
0.88
Quick Ratio
0.83

Sales & Book Value

Annual Sales
$7.66 million
Price / Sales
0.44
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.25 per share
Price / Book
3.06

Miscellaneous

Outstanding Shares
4,407,000
Free Float
4,534,000
Market Cap
$3.37 million
Optionable
Optionable
Beta
1.12

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:GENE) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners